Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 1:23 pm Unchanged |
2025-03-11 | 13G | UroGen Pharma Ltd. URGN |
Menora Mivtachim Holdings Ltd | 2,303,031 4.990% |
0 (Unchanged) |
Filing History |
| 2025-02-12 09:34 am Sale |
2024-12-31 | 13G | UroGen Pharma Ltd. URGN |
Adage Capital Management L.P. | 2,928,086 6.940% |
-807,655 (-21.62%) |
Filing History |
| 2025-02-05 10:09 am Sale |
2024-12-31 | 13G | UroGen Pharma Ltd. URGN |
MORGAN STANLEY MS |
752,861 1.800% |
-1,419,466 (-65.34%) |
Filing History |
| 2024-11-18 06:16 am Purchase |
2024-03-14 | 13D | Eloxx Pharmaceuticals, Inc. ELOX |
Pontifax Management III G.P. (2011) Ltd. | 1,485,168 4.400% |
1,485,168 (New Position) |
Filing History |
| 2024-11-14 7:46 pm Sale |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
Point72 Asset Management, L.P. | 1,520,007 3.600% |
-1,049,819 (-40.85%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
RA Capital Management, L.P. | 3,206,271 7.100% |
122,713 (+3.98%) |
Filing History |
| 2024-11-14 4:47 pm Sale |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
GREAT POINT PARTNERS LLC | 758,786 1.800% |
-1,861,759 (-71.04%) |
Filing History |
| 2024-11-14 12:04 pm Unchanged |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
Menora Mivtachim Holdings Ltd | 2,303,031 5.470% |
0 (Unchanged) |
Filing History |
| 2024-11-14 08:37 am Unchanged |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
COWEN AND COMPANY, LLC | 1,796,589 4.300% |
0 (Unchanged) |
Filing History |
| 2024-11-14 06:44 am Purchase |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
RTW Investments, LP | 4,930,204 9.990% |
3,203,396 (+185.51%) |
Filing History |
| 2024-11-12 09:30 am Purchase |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
Adage Capital Management L.P. | 3,735,741 8.870% |
3,735,741 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
BLACKROCK INC BLK |
2,497,943 5.900% |
0 (Unchanged) |
Filing |
| 2024-11-06 1:50 pm Purchase |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
MORGAN STANLEY MS |
2,172,327 5.200% |
2,172,327 (New Position) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
BLACKROCK INC BLK |
2,497,943 5.900% |
828,400 (+49.62%) |
Filing |
| 2024-06-24 5:25 pm Purchase |
2024-06-19 | 13G | UroGen Pharma Ltd. URGN |
COWEN AND COMPANY, LLC | 1,796,589 4.360% |
1,796,589 (New Position) |
Filing History |
| 2024-06-24 4:51 pm Purchase |
2024-06-14 | 13G | UroGen Pharma Ltd. URGN |
Point72 Asset Management, L.P. | 2,569,826 6.200% |
2,569,826 (New Position) |
Filing History |
| 2024-05-08 2:22 pm Sale |
2024-04-30 | 13G | UroGen Pharma Ltd. URGN |
BLACKROCK INC BLK |
1,669,543 4.600% |
-49,761 (-2.89%) |
Filing |
| 2024-02-22 09:23 am Unchanged |
2023-07-28 | 13D | UroGen Pharma Ltd. URGN |
Moshe Arkin | 1,369,315 4.440% |
0 (Unchanged) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
RA Capital Management, L.P. | 3,083,558 9.990% |
8 (+0.00%) |
Filing History |
| 2024-02-14 4:38 pm Unchanged |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
GREAT POINT PARTNERS LLC | 2,620,545 8.490% |
0 (Unchanged) |
Filing History |